Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 158

Similar articles for PubMed (Select 22451662)

1.

Reduction of Na/K-ATPase potentiates marinobufagenin-induced cardiac dysfunction and myocyte apoptosis.

Liu C, Bai Y, Chen Y, Wang Y, Sottejeau Y, Liu L, Li X, Lingrel JB, Malhotra D, Cooper CJ, Shapiro JI, Xie ZJ, Tian J.

J Biol Chem. 2012 May 11;287(20):16390-8. doi: 10.1074/jbc.M111.304451. Epub 2012 Mar 27.

2.

Association of PI3K-Akt signaling pathway with digitalis-induced hypertrophy of cardiac myocytes.

Liu L, Zhao X, Pierre SV, Askari A.

Am J Physiol Cell Physiol. 2007 Nov;293(5):C1489-97. Epub 2007 Aug 29.

3.

Marinobufagenin enhances cardiac contractility in mice with ouabain-sensitive alpha1 Na+-K+-ATPase.

Wansapura AN, Lasko V, Xie Z, Fedorova OV, Bagrov AY, Lingrel JB, Lorenz JN.

Am J Physiol Heart Circ Physiol. 2009 Jun;296(6):H1833-9. doi: 10.1152/ajpheart.00285.2009. Epub 2009 Apr 17.

4.

Reduction of Na/K-ATPase affects cardiac remodeling and increases c-kit cell abundance in partial nephrectomized mice.

Drummond CA, Sayed M, Evans KL, Shi H, Wang X, Haller ST, Liu J, Cooper CJ, Xie Z, Shapiro JI, Tian J.

Am J Physiol Heart Circ Physiol. 2014 Jun 15;306(12):H1631-43. doi: 10.1152/ajpheart.00102.2014. Epub 2014 Apr 18.

5.

Na+/K+-ATPase inhibition by ouabain induces CaMKII-dependent apoptosis in adult rat cardiac myocytes.

Sapia L, Palomeque J, Mattiazzi A, Petroff MV.

J Mol Cell Cardiol. 2010 Sep;49(3):459-68. doi: 10.1016/j.yjmcc.2010.04.013. Epub 2010 May 4.

PMID:
20435043
6.

Changes in sodium pump expression dictate the effects of ouabain on cell growth.

Tian J, Li X, Liang M, Liu L, Xie JX, Ye Q, Kometiani P, Tillekeratne M, Jin R, Xie Z.

J Biol Chem. 2009 May 29;284(22):14921-9. doi: 10.1074/jbc.M808355200. Epub 2009 Mar 27.

7.

Bidirectional regulation of nuclear factor-κB and mammalian target of rapamycin signaling functionally links Bnip3 gene repression and cell survival of ventricular myocytes.

Dhingra R, Gang H, Wang Y, Biala AK, Aviv Y, Margulets V, Tee A, Kirshenbaum LA.

Circ Heart Fail. 2013 Mar;6(2):335-43. doi: 10.1161/CIRCHEARTFAILURE.112.000061. Epub 2013 Feb 8.

8.

Examination of the cellular mechanisms by which marinobufagenin inhibits cytotrophoblast function.

Uddin MN, Horvat D, Glaser SS, Mitchell BM, Puschett JB.

J Biol Chem. 2008 Jun 27;283(26):17946-53. doi: 10.1074/jbc.M800958200. Epub 2008 Apr 23.

9.

Cell signaling associated with Na(+)/K(+)-ATPase: activation of phosphatidylinositide 3-kinase IA/Akt by ouabain is independent of Src.

Wu J, Akkuratov EE, Bai Y, Gaskill CM, Askari A, Liu L.

Biochemistry. 2013 Dec 17;52(50):9059-67. doi: 10.1021/bi4011804. Epub 2013 Nov 23.

10.

Na(+)/K)+)-ATPase α2-isoform preferentially modulates Ca2(+) transients and sarcoplasmic reticulum Ca2(+) release in cardiac myocytes.

Despa S, Lingrel JB, Bers DM.

Cardiovasc Res. 2012 Sep 1;95(4):480-6. doi: 10.1093/cvr/cvs213. Epub 2012 Jun 27.

11.

Regulation of cardiac myocyte contractility by phospholemman: Na+/Ca2+ exchange versus Na+ -K+ -ATPase.

Song J, Zhang XQ, Wang J, Cheskis E, Chan TO, Feldman AM, Tucker AL, Cheung JY.

Am J Physiol Heart Circ Physiol. 2008 Oct;295(4):H1615-25. doi: 10.1152/ajpheart.00287.2008. Epub 2008 Aug 15.

12.

Myocardial PKC beta2 and the sensitivity of Na/K-ATPase to marinobufagenin are reduced by cicletanine in Dahl hypertension.

Fedorova OV, Talan MI, Agalakova NI, Droy-Lefaix MT, Lakatta EG, Bagrov AY.

Hypertension. 2003 Mar;41(3):505-11. Epub 2003 Feb 10.

13.

Effects of cardiac glycosides on sodium pump expression and function in LLC-PK1 and MDCK cells.

Liu J, Periyasamy SM, Gunning W, Fedorova OV, Bagrov AY, Malhotra D, Xie Z, Shapiro JI.

Kidney Int. 2002 Dec;62(6):2118-25.

15.

Inhibition of Na/K-ATPase promotes myocardial tumor necrosis factor-alpha protein expression and cardiac dysfunction via calcium/mTOR signaling in endotoxemia.

Zhang T, Lu X, Li J, Chidiac P, Sims SM, Feng Q.

Basic Res Cardiol. 2012 Mar;107(2):254. doi: 10.1007/s00395-012-0254-8. Epub 2012 Feb 21.

PMID:
22351078
16.

Cicletanine reverses vasoconstriction induced by the endogenous sodium pump ligand, marinobufagenin, via a protein kinase C dependent mechanism.

Bagrov AY, Dmitrieva RI, Dorofeeva NA, Fedorova OV, Lopatin DA, Lakatta EG, Droy-Lefaix MT.

J Hypertens. 2000 Feb;18(2):209-15.

PMID:
10694190
17.

Identification of a mutant α1 Na/K-ATPase that pumps but is defective in signal transduction.

Lai F, Madan N, Ye Q, Duan Q, Li Z, Wang S, Si S, Xie Z.

J Biol Chem. 2013 May 10;288(19):13295-304. doi: 10.1074/jbc.M113.467381. Epub 2013 Mar 26.

18.

Src kinase integrates PI3K/Akt and MAPK/ERK1/2 pathways in T3-induced Na-K-ATPase activity in adult rat alveolar cells.

Lei J, Ingbar DH.

Am J Physiol Lung Cell Mol Physiol. 2011 Nov;301(5):L765-71. doi: 10.1152/ajplung.00151.2011. Epub 2011 Aug 12.

19.

Natriuretic effect of bufalin in isolated rat kidneys involves activation of the Na+-K+-ATPase-Src kinase pathway.

Arnaud-Batista FJ, Costa GT, Oliveira IM, Costa PP, Santos CF, Fonteles MC, Uchôa DE, Silveira ER, Cardi BA, Carvalho KM, Amaral LS, Pôças ES, Quintas LE, Noël F, Nascimento NR.

Am J Physiol Renal Physiol. 2012 Apr 15;302(8):F959-66. doi: 10.1152/ajprenal.00130.2011. Epub 2012 Jan 11.

20.

NaKtide, a Na/K-ATPase-derived peptide Src inhibitor, antagonizes ouabain-activated signal transduction in cultured cells.

Li Z, Cai T, Tian J, Xie JX, Zhao X, Liu L, Shapiro JI, Xie Z.

J Biol Chem. 2009 Jul 31;284(31):21066-76. doi: 10.1074/jbc.M109.013821. Epub 2009 Jun 8.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk